Chemistry:LR-1111

From HandWiki

LR-1111 is an analog of GBR-12935 that was discovered by Richard Rothman and co-workers in the 1990's. It differs from GBR-12935 in that the piperazine has been expanded to a homopiperazine (azepane) ring.[1] LR-1111 is a dopamine reuptake inhibitor (DRI) with over 4000 times selectivity for the dopamine transporter (DAT) relative to the serotonin transporter (SERT) and the norepinephrine transporter (NET).[2][3]

See also

References

  1. "Development of Novel, Potent, and Selective Dopamine Reuptake Inhibitors through Alteration of the Piperazine Ring of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909)". Journal of Medicinal Chemistry 39 (24): 4704–4716. 1 January 1996. doi:10.1021/jm960305h. PMID 8941383. 
  2. "Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters". Synapse (New York, N.Y.) 14 (1): 34–39. May 1993. doi:10.1002/syn.890140106. PMID 8511716. 
  3. "Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes". The Journal of Pharmacology and Experimental Therapeutics 273 (1): 213–222. Apr 1995. doi:10.1016/S0022-3565(25)09513-8. PMID 7714769. 
  • "Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use as noncompetitive antagonists of dopamine reuptake" WO patent 9818769